Celldex Reports Phase 2 Barzolvolimab Results in Prurigo Nodularis
HAMPTON, N.J., July 21, 2026 Celldex announced topline results from its Phase 2 clinical trial evaluating barzolvolimab in patients...
Most Recent
Advertisement
Nurix and Roche Complete Strategic Oncology Collaboration
Brisbane, California, USA | July 21, 2026 Nurix Therapeutics announced the official closing of its previously announced global collaboration...
Rein Therapeutics Expands Phase 2 RENEW Trial Across Five Countries
Austin, Texas, USA | July 21, 2026 Rein Therapeutics announced that its Phase 2 RENEW clinical trial evaluating the...
Telix Publishes ProstACT SELECT Study on TLX591-Tx
Melbourne, Australia & Indianapolis, Indiana, USA | July 22, 2026 Telix Pharmaceuticals announced the peer-reviewed publication of results from...
Plus Therapeutics Secures Medical Mutual Coverage Agreement
Houston, Texas, USA | July 21, 2026 Plus Therapeutics, through its wholly owned subsidiary CNSide Diagnostics, announced a regional...
Akari and Whitehawk Launch ADC Research Partnership
Tampa, Florida, USA & London, UK | July 21, 2026 Akari Therapeutics announced a strategic research collaboration with Whitehawk...
Enterome Reports Positive Phase 2 EO2463 Results
Paris, France | July 21, 2026 Enterome SA announced positive interim Phase 1/2 clinical data from its ongoing SIDNEY...
Kyowa Kirin Wins EC Approval for Crysvita in Infants
GALASHIELS & MARLOW, United Kingdom, July 21, 2026 Kyowa Kirin EMEA has announced that the European Commission (EC) has...
Haier Biomedical Unveils Digital Blood Management Platform
KUALA LUMPUR, Malaysia, July 21, 2026 Haier Biomedical showcased its next-generation Digital Blood Management Platform at the ISBT Congress...
Tempus to Acquire Personalis in $1.5B Precision Oncology Deal
CHICAGO, July 20, 2026 Tempus AI, Inc. has entered into a definitive agreement to acquire Personalis, Inc. in a...
Advertisement
